These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27890450)

  • 1. SRC2-3 binds to vitamin D receptor with high sensitivity and strong affinity.
    Egawa D; Itoh T; Kato A; Kataoka S; Anami Y; Yamamoto K
    Bioorg Med Chem; 2017 Jan; 25(2):568-574. PubMed ID: 27890450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
    Yamamoto K
    Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-specific structural changes in the vitamin D receptor in solution.
    Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
    Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
    Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
    J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.
    Inaba Y; Nakabayashi M; Itoh T; Yoshimoto N; Ikura T; Ito N; Shimizu M; Yamamoto K
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):146-50. PubMed ID: 20211257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular Dynamics.
    Anami Y; Shimizu N; Ekimoto T; Egawa D; Itoh T; Ikeguchi M; Yamamoto K
    J Med Chem; 2016 Sep; 59(17):7888-900. PubMed ID: 27535484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
    Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
    Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.
    Yoshimoto N; Sakamaki Y; Haeta M; Kato A; Inaba Y; Itoh T; Nakabayashi M; Ito N; Yamamoto K
    J Med Chem; 2012 May; 55(9):4373-81. PubMed ID: 22512505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
    Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
    J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
    Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
    Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators.
    Mita Y; Dodo K; Noguchi-Yachide T; Miyachi H; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1712-7. PubMed ID: 20144545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
    Peräkylä M; Molnár F; Carlberg C
    Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids.
    Ikura T; Ito N
    Vitam Horm; 2016; 100():117-36. PubMed ID: 26827950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
    Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
    Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative binding sites at the vitamin D receptor and their ligands.
    Mutchie TR; Yu OB; Di Milo ES; Arnold LA
    Mol Cell Endocrinol; 2019 Apr; 485():1-8. PubMed ID: 30654005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-mediated conformational changes of the VDR are required for gene transactivation.
    Carlberg C
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.